Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer

The BRAF V600E mutation occurs in approximately 10% of patients with metastatic colorectal cancer (CRC) and constitutes a distinct subtype of the disease with extremely poor prognosis. To address this refractory disease, we investigated the unique metabolic gene profile of BRAF V600E‐mutated tumors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Yukimoto, Ryohei, Nishida, Naohiro, Hata, Tsuyoshi, Fujino, Shiki, Ogino, Takayuki, Miyoshi, Norikatsu, Takahashi, Hidekazu, Uemura, Mamoru, Satoh, Taroh, Hirofumi, Yamamoto, Mizushima, Tsunekazu, Doki, Yuichiro, Eguchi, Hidetoshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8253290/
https://ncbi.nlm.nih.gov/pubmed/33934428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14929
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados